Bioxytran, Inc (BIXT): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$104.0K
Year ended 2017-12-31
-14.4%
3-year compound annual growth
-3.1%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2017-12-31 | $104.0K | +8.0% | 2018-04-02, From 2017-01-01 |
| 2016-12-31 | $96.3K | -29.0% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $135.7K | -18.3% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $166.0K | -15.9% | 2016-09-20, From 2014-01-01 |
| 2013-12-31 | $197.4K | +61.9% | 2015-04-10, From 2013-01-01 |
| 2012-12-31 | $121.9K | +539.2% | 2014-04-14, From 2012-01-01 |
| 2011-12-31 | $19.1K | +372.8% | 2013-04-15, From 2011-01-01 |
| 2010-12-31 | $4.0K | n/a | 2012-12-31, From 2010-01-01 |